Proceedings from the eighth in a series of 11 integrated
webinars held in association with the 2020 ONS Annual Congress.
Featuring perspectives from Dr Arjun Balar, Ms Anastassia
Daskalova, Dr Peter H O’Donnell and Ms Susan K Roethke.
Introduction (00:00)
Overview of Urothelial Bladder Cancer (UBC) Management
(2:56)
Anti-PD-1/PD-L1 Antibodies for Patients with Nonmetastatic UBC
(24:34)
Risks and Benefits of Immune Checkpoint Inhibitors in Advanced
UBC (36:53)
Integration of FGFR-Directed Therapy into Current UBC
Management Algorithms (55:33)
Antibody-Drug Conjugates in UBC (1:07:40)
Management of UBC in the Era of COVID-19 (1:19:21)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.